Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_assertion type Assertion NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_head.
- NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_assertion description "[Finally, the study of associations between critical clinicopathological parameters and activated DDR factors highlighted a statistically meaningful correlation between reduced local tumor extension and the phosphorylation of ATM, CHK2 and the presence of 53BP1, whereas no significant correlations with parameters such as survival or relapse of early-stage lung carcinomas were found.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_provenance.
- NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_assertion evidence source_evidence_literature NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_provenance.
- NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_assertion SIO_000772 17522062 NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_provenance.
- NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_assertion wasDerivedFrom befree-20150227 NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_provenance.
- NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_assertion wasGeneratedBy ECO_0000203 NP255024.RAGGEBgFxPLBfWoi9M4URm29qVmzpQqk1BCDWC2HPaxs8130_provenance.